Cornerstone Robotics' Sentire® Surgical System Receives CE Approval for Global Expansion
think globally, act locally.” The company officially established its British subsidiary in 2025, launching comprehensive services that include expert training, clinical technical support, and after-sales service. It has initiated multiple training sessions within the UK, equipping clinical teams with the necessary skills and confidence to operate the Sentire® surgical system effectively. These initiatives lay the groundwork for a robust commercial rollout of their advanced surgical technology.
The competitive advantage of Cornerstone Robotics is anchored in its intensive internal research and development, coupled with a vertically integrated business model. This high level of technological integration not only enhances clinical performance and supply chain resilience but also fosters operational stability and long-term innovation.
Professor Samuel Au, the founder and CEO of Cornerstone Robotics, highlighted that obtaining the CE certification represents a significant development milestone for the company as it transitions from a technological innovator to a global clinical solutions provider. Each step of this journey reflects their commitment to innovation, product excellence, and clinical value.
Looking ahead, Cornerstone Robotics aims to expand into key global markets and forge partnerships with leading healthcare institutions to deliver high-quality surgical robotic solutions to more doctors and patients.
The CE certification marks a vital step in Cornerstone Robotics' European market expansion and broader journey towards global commercialization. In November 2025, the company successfully completed a funding round with exceptional demand, raising approximately $200 million. This influx underscores strong confidence from leading international investors in its long-term growth potential and business capabilities.
Coupled with proprietary technological advancements and robust strategic resources, Cornerstone Robotics is well-positioned to accelerate the global deployment of high-quality, accessible surgical robotic solutions for healthcare professionals and patients alike.
Cornerstone Robotics is an innovative "unicorn" in surgical robotics, dedicated to advancing medical innovations for a healthier world. The company enhances surgical care with state-of-the-art robotic systems aimed at increasing the accessibility and efficiency of quality healthcare globally. With three global research and development centers and six business branches worldwide, Cornerstone has established a 30,000 square meter manufacturing facility in China. The Sentire® surgical system, developed entirely in-house, has undergone clinical testing across various specialties and is now approved for market entry in China, the EU, and Singapore, pushing high-quality surgical care to a global standard.
For more information, visit Cornerstone Robotics.
Leveraging Research and Development for Quality Global Expansion
The competitive advantage of Cornerstone Robotics is anchored in its intensive internal research and development, coupled with a vertically integrated business model. This high level of technological integration not only enhances clinical performance and supply chain resilience but also fosters operational stability and long-term innovation.
Professor Samuel Au, the founder and CEO of Cornerstone Robotics, highlighted that obtaining the CE certification represents a significant development milestone for the company as it transitions from a technological innovator to a global clinical solutions provider. Each step of this journey reflects their commitment to innovation, product excellence, and clinical value.
Looking ahead, Cornerstone Robotics aims to expand into key global markets and forge partnerships with leading healthcare institutions to deliver high-quality surgical robotic solutions to more doctors and patients.
Financial Strength and Future Prospects
The CE certification marks a vital step in Cornerstone Robotics' European market expansion and broader journey towards global commercialization. In November 2025, the company successfully completed a funding round with exceptional demand, raising approximately $200 million. This influx underscores strong confidence from leading international investors in its long-term growth potential and business capabilities.
Coupled with proprietary technological advancements and robust strategic resources, Cornerstone Robotics is well-positioned to accelerate the global deployment of high-quality, accessible surgical robotic solutions for healthcare professionals and patients alike.
About Cornerstone Robotics
Cornerstone Robotics is an innovative "unicorn" in surgical robotics, dedicated to advancing medical innovations for a healthier world. The company enhances surgical care with state-of-the-art robotic systems aimed at increasing the accessibility and efficiency of quality healthcare globally. With three global research and development centers and six business branches worldwide, Cornerstone has established a 30,000 square meter manufacturing facility in China. The Sentire® surgical system, developed entirely in-house, has undergone clinical testing across various specialties and is now approved for market entry in China, the EU, and Singapore, pushing high-quality surgical care to a global standard.
For more information, visit Cornerstone Robotics.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.